Integrative Gastroenterology Weil Integrative Medicine Library

Total Page:16

File Type:pdf, Size:1020Kb

Integrative Gastroenterology Weil Integrative Medicine Library Integrative Gastroenterology Weil Integrative Medicine Library Published and Forthcoming Volumes series editor andrew weil, md Donald I. Abrams and Andrew Weil: Integrative Oncology Timothy Culbert and Karen Olness: Integrative Pediatrics Gerard E. Mullin: Integrative Gastroenterology Victoria Maizes and Tieraona Low Dog: Integrative Women’s Health Randy Horwitz and Daniel Muller: Integrative Rheumatology Daniel A. Monti and Bernard Beitman: Integrative Psychiatry Stephen Devries and James Dalen: Integrative Cardiology Integrative Gastroenterology edited by Gerard E. Mullin, MD Associate Professor, Medicine Johns Hopkins University School of Medicine The Johns Hopkins Hospital Baltimore, MD 1 1 Published in the United States of America by Oxford University Press, Inc., 198 Madison Avenue, New York, NY, 10016 United States of America Oxford University Press, Inc. publishes works that further Oxford University’s objective of excellence in research, scholarship, and education Oxford is a registered trademark of Oxford University Press in the UK and in certain other countries © Oxford University Press, Inc. 2011 All rights reserved. No part of this publication may be reproduced, stored in a retrieval system, or transmitted, in any form or by any means, without the prior permission in writing of Oxford University Press, Inc., or as expressly permitted by law, by licence, or under terms agreed with the appropriate reproduction rights organization. Inquiries concerning reproduction outside the scope of the above should be sent to the Rights Department, Oxford University Press, Inc., at the address above You must not circulate this work in any other form and you must impose this same condition on any acquirer ____________________________________________ Library of Congress Cataloging-in-Publication Data Integrative gastroenterology/[edited by] Gerard E. Mullin. p.; cm.—(Weil integrative medicine library) Includes bibliographical references and index. ISBN-13: 978-0-19-537110-9 (alk. paper) ISBN-10: 0-19-537110-0 (alk. paper) 1. Gastrointestinal system—Diseases. 2. Integrative medicine. I. Mullin, Gerard E. II. Series: Weil integrative medicine library. [DNLM: 1. Gastrointestinal Diseases—therapy. 2. Complementary Th erapies—methods. WI 140 I605 2010] RC817.I47 2010 616.3’3—dc22 2009023877 978-0-19537110-9 ____________________________________________ 1 3 5 7 9 10 8 6 4 2 Typeset in Minion Pro Regular Printed on acid-free paper Printed in the United States of America Th is material is not intended to be, and should not be considered, a substitute for medical or other professional advice. Treatment for the conditions described in this material is highly dependent on the individual circumstances. And, while this material is designed to off er accurate information with respect to the subject matter covered and to be current as of the time it was written, research and knowledge about medical and health issues is constantly evolving and dose schedules for medications are being revised continually, with new side eff ects recognized and accounted for regularly. Readers must therefore always check the product information and clinical procedures with the most up-to-date published product information and data sheets provided by the manufacturers and the most recent codes of conduct and safety regulation. Th e publisher and the authors make no representations or warranties to readers, express or implied, as to the accuracy or completeness of this material. Without limiting the foregoing, the publisher and the authors make no representations or warranties as to the accuracy or effi cacy of the drug dosages mentioned in the material. Th e authors and the publisher do not accept, and expressly disclaim, any responsibility for any liability, loss or risk that may be claimed or incurred as a consequence of the use and/or application of any of the contents of this material. To the more than 70 million Americans who are known to suff er from digestive disorders. To my loved ones for their unwavering support over the years. To the many who mentored me throughout my career. To Andrew Weil MD for selecting me to edit this textbook. And the beloved memory of my parents. This page intentionally left blank FOREWORD few years ago, a leading gastroenterologist in Tucson asked me to meet with him. Over dinner, he expressed the hope that integrative A medicine (IM) might have something to off er him. He was frustrated, he said, because, “ninety percent of the patients I see have problems that my training does not enable me to solve.” At that time, the Arizona Center for Integrative Medicine was off ering a comprehensive IM fellowship in distributed learning format to physicians and nurse practitioners. We were training family medicine doctors, internists, and surgeons, but had not yet had a GI specialist apply. Th at disappointed me, because I knew that integrative medicine could greatly enrich the fi eld of gas- troenterology, increasing its effi cacy and reducing the frustration expressed by my colleague in Tucson and shared by many others. One of the core curricular areas of IM is mind/body medicine. It covers the theory and evidence base for interactions between mental/emotional states and physiology, as well as therapies that take advantage of those interactions. Steven Gurgevich, PhD, a clinical psychologist on the faculty of the American Society of Clinical Hypnosis, helped design the mind/body medicine module. He has said, “Patients with gastrointestinal problems should be seen by hypno- therapists before they go to gastroenterologists,” and over the years, I have referred many patients with GI complaints to him and other mind/body prac- titioners, with good outcomes. His reasoning is that the organs of the GI system, along with the skin, have the greatest amount of innervation of any organs and, as a result, are the most frequent sites of expression of stress- related disorders. Michael Gershon, MD, chairman of the Department of vii viii FOREWORD Anatomy and Cell Biology at Columbia University Medical Center, in an excel- lent book on enteric neurology, refers to the gut as the “second brain.” Many common GI disorders arise from disturbed function of the gut—in particular, an imbalance between its intrinsic motility and extrinsic control by the autonomic nervous system (oft en caused by stress-related overactivity of the sympathetic nerves). Without harmonious coordination, gut motility is abnormal and digestion impaired. In late stages of these disorders, we can visualize or otherwise detect pathological changes, but early on they present as functional complaints. Patients seek relief of GI symptoms; there are few or no measurable correlates of the symptoms. “Functional disorder” is a loaded term in conventional medicine. Oft en it is used to dismiss complaints of patients without visible pathology; at worst, it is used as a synonym for “imagined disease.” Patients are easily angered by sug- gestions that their GI problems are all in the mind. Practitioners must be able to help them understand the underlying somatopsychic mechanism that accounts for their very real symptoms. Traditional Chinese medicine (TCM) classifi es diseases as “visible” or “invisible” and postulates that all visible disease is preceded by an invisible stage, in which “energy” (chi) circulation through the body is disturbed. TCM practitioners believe that if invisible disease goes untreated (by acupuncture, herbal therapy, dietary adjustment, etc.), it will eventually produce pathologi- cal changes in the physical structure of the body. Th erefore, TCM prioritizes the diagnosis and treatment of what conventional Western medicine oft en dis- misses as functional disorders. Doctors here tend to minimize the signifi cance of these problems, in part because they fi nd it frustrating to manage them. Th eir training does not enable them to do so. Because dietary habits and other lifestyle factors can both trigger and aggra- vate this class of GI disorders, it is not suffi cient to send patients to stress- management training or hypnotherapy. Physicians must also give them specifi c recommendations about foods, beverages, physical activity, rest and sleep, and more. And they should know when the pharmaceutical drugs now so widely prescribed for GI problems are really indicated, and for how long patients should be on them. Proton-pump inhibitors for GERD and steroids for infl am- matory bowel disease may be useful for short-term suppression of symptoms, but over time the benefi t-to-risk ratio changes signifi cantly and unfavorably, and data on the risks are accumulating. Practitioners of integrative medicine are fully trained to diagnose and treat invisible and functional disease before it damages tissues and organs and requires drastic, costly intervention. Th ey work from the premise that the body can heal itself if given a chance, that mind/body interactions are real and oft en very relevant to issues of health and illness, that all aspects of lifestyle must be FOREWORD ix considered in evaluating patients, and that the doctor/patient relationship is a key factor in the outcome of treatment. In addition, they are familiar with a wide range of therapeutic options other than drugs. In recommending thera- pies not commonly included in mainstream practice, they pay attention to the evidence that supports them, always working from the principle that the greater the potential of a treatment to cause harm, the stricter the standards of evidence for effi cacy it must be held to. A major
Recommended publications
  • Herbal Medicines in Pregnancy and Lactation : an Evidence-Based
    00 Prelims 1410 10/25/05 2:13 PM Page i Herbal Medicines in Pregnancy and Lactation An Evidence-Based Approach Edward Mills DPh MSc (Oxon) Director, Division of Clinical Epidemiology Canadian College of Naturopathic Medicine North York, Ontario, Canada Jean-Jacques Duguoa MSc (cand.) ND Naturopathic Doctor Toronto Western Hospital Assistant Professor Division of Clinical Epidemiology Canadian College of Naturopathic Medicine North York, Ontario, Canada Dan Perri BScPharm MD MSc Clinical Pharmacology Fellow University of Toronto Toronto, Ontario, Canada Gideon Koren MD FACMT FRCP Director of Motherisk Professor of Medicine, Pediatrics and Pharmacology University of Toronto Toronto, Ontario, Canada With a contribution from Paul Richard Saunders PhD ND DHANP 00 Prelims 1410 10/25/05 2:13 PM Page ii © 2006 Taylor & Francis Medical, an imprint of the Taylor & Francis Group First published in the United Kingdom in 2006 by Taylor & Francis Medical, an imprint of the Taylor & Francis Group, 2 Park Square, Milton Park, Abingdon, Oxon OX14 4RN Tel.: ϩ44 (0)20 7017 6000 Fax.: ϩ44 (0)20 7017 6699 E-mail: [email protected] Website: www.tandf.co.uk/medicine All rights reserved. No part of this publication may be reproduced, stored in a retrieval system, or trans- mitted, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise, without the prior permission of the publisher or in accordance with the provisions of the Copyright, Designs and Patents Act 1988 or under the terms of any licence permitting limited copying issued by the Copyright Licensing Agency, 90 Tottenham Court Road, London W1P 0LP.
    [Show full text]
  • Ginger, the Genus Zingiber {P. N. Ravindran}
    Ginger The Genus Zingiber Ginger The Genus Zingiber Edited by P.N. Ravindran and K. Nirmal Babu Medicinal and Aromatic Plants — Industrial Profiles CRC PRESS Boca Raton London New York Washington, D.C. Library of Congress Cataloging-in-Publication Data Ginger : the genus Zingiber / edited by P.N. Ravindran, K. Nirmal Babu. p. cm.—(Medicinal and aromatic plants—industrial profiles; v. 41) Includes bibliographical references (p. ). ISBN 0-415-32468-8 (alk. Paper) 1. Ginger. I. Ravindran, P.N. II. Nirmal Babu, K. III. Series. SB304.G56 2004 633.8'3—dc22 2004055370 This book contains information obtained from authentic and highly regarded sources. Reprinted material is quoted with permission, and sources are indicated. A wide variety of references are listed. Reasonable efforts have been made to publish reliable data and information, but the author and the publisher cannot assume responsibility for the validity of all materials or for the consequences of their use. Neither this book nor any part may be reproduced or transmitted in any form or by any means, electronic or mechanical, including photocopying, microfilming, and recording, or by any information storage or retrieval system, without prior permission in writing from the publisher. All rights reserved. Authorization to photocopy items for internal or personal use, or the personal or internal use of specific clients, may be granted by CRC Press, provided that $1.50 per page photocopied is paid directly to Copyright Clearance Center, 222 Rosewood Drive, Danvers, MA 01923 USA. The fee code for users of the Transactional Reporting Service is ISBN 0-415-32468-8/05/$0.00+$1.50.
    [Show full text]
  • Dr. Duke's Phytochemical and Ethnobotanical Databases List of Chemicals for Migraine
    Dr. Duke's Phytochemical and Ethnobotanical Databases List of Chemicals for Migraine Chemical Activity Count (+)-ALLOMATRINE 1 (+)-ALPHA-VINIFERIN 1 (+)-BORNYL-ISOVALERATE 1 (+)-CATECHIN 3 (+)-EUDESMA-4(14),7(11)-DIENE-3-ONE 1 (+)-GALLOCATECHIN 1 (+)-HERNANDEZINE 1 (+)-ISOCORYDINE 3 (+)-PSEUDOEPHEDRINE 1 (+)-T-CADINOL 1 (-)-16,17-DIHYDROXY-16BETA-KAURAN-19-OIC 1 (-)-ALPHA-BISABOLOL 3 (-)-ANABASINE 1 (-)-APOGLAZIOVINE 1 (-)-ARGEMONINE 1 (-)-BETONICINE 1 (-)-BORNYL-CAFFEATE 1 (-)-BORNYL-FERULATE 1 (-)-BORNYL-P-COUMARATE 1 (-)-DICENTRINE 2 (-)-EPIAFZELECHIN 1 (-)-EPICATECHIN 2 (-)-EPIGALLOCATECHIN-GALLATE 1 (1'S)-1'-ACETOXYCHAVICOL-ACETATE 1 (15:1)-CARDANOL 1 (E)-4-(3',4'-DIMETHOXYPHENYL)-BUT-3-EN-OL 1 0-METHYLCORYPALLINE 2 Chemical Activity Count 1,7-BIS-(4-HYDROXYPHENYL)-1,4,6-HEPTATRIEN-3-ONE 1 1,8-CINEOLE 7 10-ACETOXY-8-HYDROXY-9-ISOBUTYLOXY-6-METHOXYTHYMOL 1 10-DEHYDROGINGERDIONE 1 10-GINGERDIONE 1 11-HYDROXY-DELTA-8-THC 1 11-HYDROXY-DELTA-9-THC 1 12,118-BINARINGIN 1 12-ACETYLDEHYDROLUCICULINE 1 12-METHOXYDIHYDROCOSTULONIDE 1 13',II8-BIAPIGENIN 1 13-OXYINGENOL-ESTER 1 14-ACETOXYCEDROL 1 16,17-DIHYDROXY-16BETA-KAURAN-19-OIC 1 16-EPIMETHUENINE 1 16-HYDROXYINGENOL-ESTER 1 2'-HYDROXY-FLAVONE 1 2'-O-GLYCOSYLVITEXIN 1 2-BETA,3BETA-27-TRIHYDROXYOLEAN-12-ENE-23,28-DICARBOXYLIC-ACID 1 2-METHYLBUT-3-ENE-2-OL 2 2-NAPTHOL 1 20-DEOXYINGENOL-ESTER 1 22BETA-ESCIN 1 24-METHYLENE-CYCLOARTANOL 2 3,4-DIMETHOXYTOLUENE 1 3,4-METHYLENE-DIOXYCINNAMIC-ACID-BORNYL-ESTER 2 3,4-SECOTRITERPENE-ACID-20-EPI-KOETJAPIC-ACID 1 2 Chemical Activity Count 3-ACETYLACONITINE
    [Show full text]
  • Cover Next Page > Cover Next Page >
    cover next page > Cover title: The Psychopharmacology of Herbal Medicine : Plant Drugs That Alter Mind, Brain, and Behavior author: Spinella, Marcello. publisher: MIT Press isbn10 | asin: 0262692651 print isbn13: 9780262692656 ebook isbn13: 9780585386645 language: English subject Psychotropic drugs, Herbs--Therapeutic use, Psychopharmacology, Medicinal plants--Psychological aspects. publication date: 2001 lcc: RC483.S65 2001eb ddc: 615/.788 subject: Psychotropic drugs, Herbs--Therapeutic use, Psychopharmacology, Medicinal plants--Psychological aspects. cover next page > < previous page page_i next page > Page i The Psychopharmacology of Herbal Medicine < previous page page_i next page > cover next page > Cover title: The Psychopharmacology of Herbal Medicine : Plant Drugs That Alter Mind, Brain, and Behavior author: Spinella, Marcello. publisher: MIT Press isbn10 | asin: 0262692651 print isbn13: 9780262692656 ebook isbn13: 9780585386645 language: English subject Psychotropic drugs, Herbs--Therapeutic use, Psychopharmacology, Medicinal plants--Psychological aspects. publication date: 2001 lcc: RC483.S65 2001eb ddc: 615/.788 subject: Psychotropic drugs, Herbs--Therapeutic use, Psychopharmacology, Medicinal plants--Psychological aspects. cover next page > < previous page page_ii next page > Page ii This page intentionally left blank. < previous page page_ii next page > < previous page page_iii next page > Page iii The Psychopharmacology of Herbal Medicine Plant Drugs That Alter Mind, Brain, and Behavior Marcello Spinella < previous page page_iii next page > < previous page page_iv next page > Page iv © 2001 Massachusetts Institute of Technology All rights reserved. No part of this book may be reproduced in any form by any electronic or mechanical means (including photocopying, recording, or information storage and retrieval) without permission in writing from the publisher. This book was set in Adobe Sabon in QuarkXPress by Asco Typesetters, Hong Kong and was printed and bound in the United States of America.
    [Show full text]
  • Final Assessment Report on Zingiber Officinale Roscoe, Rhizoma
    27 March 2012 EMA/HMPC/577856/2010 Committee on Herbal Medicinal Products (HMPC) Assessment report on Zingiber officinale Roscoe, rhizoma Based on Article 10a of Directive 2001/83/EC as amended (well-established use) Based on Article 16d(1), Article 16f and Article 16h of Directive 2001/83/EC as amended (traditional use) Final Herbal substance(s) (binomial scientific name Zingiber officinale Roscoe, rhizoma. of the plant, including plant part) Herbal preparation(s) Powdered herbal substance. Pharmaceutical form(s) Herbal preparations in solid dosage forms for oral use. Rapporteur Steffen Bager Assessor(s) Dr Med. Lars Ovesen 7 Westferry Circus ● Canary Wharf ● London E14 4HB ● United Kingdom Telephone +44 (0)20 7418 8400 Facsimile +44 (0)20 7523 7051 E-mail [email protected] Website www.ema.europa.eu An agency of the European Union © European Medicines Agency, 2012. Reproduction is authorised provided the source is acknowledged. Table of contents Table of contents ................................................................................................................... 2 1. Introduction ....................................................................................................................... 4 1.1. Description of the herbal substance(s), herbal preparation(s) or combinations thereof .. 4 1.2. Information about products on the market in the Member States ............................... 5 1.3. Search and assessment methodology ..................................................................... 8 2. Historical data
    [Show full text]
  • Anti-Emetic Mechanisms of Zingiber Officinale Against Cisplatin Induced
    Ullah et al. BMC Complementary and Alternative Medicine (2015) 15:34 DOI 10.1186/s12906-015-0556-0 RESEARCH ARTICLE Open Access Anti-emetic mechanisms of zingiber officinale against cisplatin induced emesis in the pigeon; behavioral and neurochemical correlates Ihsan Ullah1,2*, Fazal Subhan2, Muhammad Ayaz3, Rehmat Shah2,5, Gowhar Ali2, Ikram Ul Haq4 and Sami Ullah2 Abstract Background: Zingiber officinale (ZO, family Zingiberaceae) has been reported for its antiemetic activity against cancer chemotherapy induced emesis in animal models and in clinics. Current study was designed to investigate ZO for potential usefulness against cisplatin induced vomiting in pigeon and its effects on central and peripheral neurotransmitters involved in the act of vomiting. Methods: Zingiber officinale acetone fraction (ZO-ActFr) was investigated for attenuation of emesis induced by cisplatin in healthy pigeons. Neurotransmitters DA, 5HT and their metabolites DOPAC, HVA and 5HIAA were analyzed using High Performance Liquid Chromatography system coupled with electrochemical detector in area postrema, brain stem and intestine. Antiemetic effect of ZO-ActFr was correlated with central and intestinal neurotransmitters levels in pigeon. Results: Cisplatin (7 mg/kg i.v.) induced emesis without lethality upto the observation period. ZO-ActFr (25, 50 & 100 mg/kg) attenuated cisplatin induced emesis ~ 44.18%, 58.13% (P < 0.05) and 27.9%, respectively; the reference drug, metoclopramide (MCP; 30 mg/kg), produced ~ 48.83% reduction (P < 0.05). ZO-ActFr reduced (P < 0.05 - 0.001) 5-hydroxytryptamine (5HT) concentration in the area postrema, brain stem and intestine at 3rd hour of cisplatin administration, while at the 18th hour ZO treatments attenuated the dopamine upsurge (P < 0.001) caused by cisplatin in the area postrema and 5HT concentration (P < 0.01 - 0.001) in the brain stem and intestine.
    [Show full text]
  • Navigating the Myths and Truths Behind Pharmacological Drug and Herbal Supplement Use: a Guide for Pregnant Women
    Regis University ePublications at Regis University All Regis University Theses Spring 2019 Navigating the Myths and Truths Behind Pharmacological Drug and Herbal Supplement Use: A Guide for Pregnant Women Angela Vu Follow this and additional works at: https://epublications.regis.edu/theses Part of the Alternative and Complementary Medicine Commons, Bioethics and Medical Ethics Commons, and the Hormones, Hormone Substitutes, and Hormone Antagonists Commons Recommended Citation Vu, Angela, "Navigating the Myths and Truths Behind Pharmacological Drug and Herbal Supplement Use: A Guide for Pregnant Women" (2019). All Regis University Theses. 931. https://epublications.regis.edu/theses/931 This Thesis - Open Access is brought to you for free and open access by ePublications at Regis University. It has been accepted for inclusion in All Regis University Theses by an authorized administrator of ePublications at Regis University. For more information, please contact [email protected]. Navigating the Myths and Truths Behind Pharmacological Drug and Herbal Supplement Use: A Guide for Pregnant Women A thesis submitted to Regis College The Honors Program In partial fulfillment of the requirements for Graduation with Honors Angela Vu Honors Thesis May 2019 i Thesis Written By Angela Vu Approved By: Thesis Advisor Thesis Reader or Co-advisor Accepted By: Director, University Honors Program ii iii Table of Contents List of Figures ...............................................................................................................................
    [Show full text]
  • WO 2018/005695 Al O
    (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International Publication Date W O 2018/005695 A l 0 4 January 2018 (04.01.2018) W ! P O PCT (51) International Patent Classification: (72) Inventors: BASTA, Steven; 590 Berkeley Avenue, Menlo A61K 31/4035 (2006.01) A61P 17/04 (2006.01) Park, CA 94025 (US). JOING, Mark; 936 Clara Drive, Pa A61K 45/06 (2006.01) lo Alto, CA 94303 (US). ZHANG, Xiaoming; 1089 Rem- sen Court, Sunnyvale, CA 94087 (US). KWON, Paul; 3349 (21) International Application Number: Deer Hollow Dr, Danville, CA 94506 (US). PCT/US20 17/039829 (74) Agent: SILVERMAN, Lisa, N.; Morrison & Foerster LLP, (22) International Filing Date: 755 Page Mill Road, Palo Alto, CA 94304-1018 (US). 28 June 2017 (28.06.2017) (81) Designated States (unless otherwise indicated, for every (25) Filing Language: English kind of national protection available): AE, AG, AL, AM, (26) Publication Language: English AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, (30) Priority Data: DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, 62/356,280 29 June 2016 (29.06.2016) US HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, 62/356,291 29 June 2016 (29.06.2016) US KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, 62/356,301 29 June 2016 (29.06.2016) us MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, 62/356,294 29 June 2016 (29.06.2016) us OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, 62/356,286 29 June 2016 (29.06.2016) us SC, SD, SE, SG, SK, SL, SM, ST, SV, SY,TH, TJ, TM, TN, 62/356,271 29 June 2016 (29.06.2016) us TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
    [Show full text]
  • Chemistry of Spices This Page Intentionally Left Blank Chemistry of Spices
    Chemistry of Spices This page intentionally left blank Chemistry of Spices Edited by Villupanoor A. Parthasarathy Indian Institute of Spices Research Calicut, Kerala, India Bhageerathy Chempakam Indian Institute of Spices Research Calicut, Kerala, India and T. John Zachariah Indian Institute of Spices Research Calicut, Kerala, India CABI is a trading name of CAB International CABI Head Offi ce CABI North American Offi ce Nosworthy Way 875 Massachusetts Avenue Wallingford 7th Floor Oxfordshire OX10 8DE Cambridge, MA 02139 UK USA Tel: +44 (0)1491 832111 Tel: +1 617 395 4056 Fax: +44 (0)1491 833508 Fax: +1 617 354 6875 E-mail: [email protected] E-mail: [email protected] Website: www.cabi.org ©CAB International 2008. All rights reserved. No part of this publication may be reproduced in any form or by any means, electronically, mechanically, by photocopying, recording or otherwise, without the prior permission of the copyright owners. A catalogue record for this book is available from the British Library, London, UK. Library of Congress Cataloging-in-Publication Data Chemistry of spices / [edited by] V.A. Parthasarathy, B. Chempakam, T. John Zachariah. p. cm. Includes bibliographical references and index. ISBN 978-1-84593-405-7 (alk. paper) 1. Spices--Analysis. 2. Spice plants--Composition. I. Parthasarathy, V.A. II. Chempakam, B., Dr. III. Zachariah, T. John. IV. Title. SB305.C44 2008 641.3'383--dc22 2007043551 ISBN-13: 978 1 84593 405 7 Typeset by Spi, Pondicherry, India. Printed and bound in the UK by Biddles Ltd, King’s Lynn. Contents Contributors vii Preface ix 1 Introduction 1 V.A.
    [Show full text]
  • Ginger Extract Defies Changes in Brain Serotonin Levels and Enzymes of Monoamine Metabolism During Withdrawal Following Chronic Ethanol Ingestion
    Global Journal of Biotechnology & Biochemistry 7 (4): 115-124, 2012 ISSN 2078-466X © IDOSI Publications, 2012 DOI: 10.5829/idosi.gjbb.2012.7.4.84214 Ginger Extract Defies Changes In Brain Serotonin Levels and Enzymes of Monoamine Metabolism During Withdrawal Following Chronic Ethanol Ingestion Swaroopa Marella and K. Sathyavelu Reddy Department of Zoology, Division of Exercise Physiology and Molecular Biology, Sri Venkateswara University, Tirupati-517502 Andhra Pradesh, India Abstract: In this study, the ameliorative effects of ginger extract on catecholamine metabolism were investigated in different brain regions of male wistar rats 72h post chronic ethanol (EtOH) ingestion. Main methods:Ethanol (2% w/v) was administered to rats by orogastric intubation. Biochemical investigation was performed for monoamine metabolising enzymes in five groups: (i) Control, (ii) EtOH treated, (iii) EtOH treated along with ginger extract (iv) Ethanol withdrawal (EW) and (v) EtOH withdrawal along with ginger extract groups of rats. Rats in each group were decapitated after six weeks except for the withdrawal groups, which were sacrificed 72h after the last dose of ethanol administration. The brains were removed and cerebral cortex, hippocampus, pons medulla and cerebellum were dissected. The biochemical estimations were done by conventional spectrophotometry. Key findings: Most significant difference in serotonin levels and monoamine metabolizing enzyme activities is observed among normal, ethanol treated and ethanol withdrawal groups (p<0.01). However, the serotonin levels and monoamine metabolizing enzyme activities in both EtOH + ginger extract and EtOH withdrawal + ginger extract group of rats was much lower as compared to the control group (p<0.05). The differences between EtOH intoxicated model and EW experimental group in comparison with their respective ginger extract treated groups, were highly significant(p<0.01).
    [Show full text]
  • Dr. Duke's Phytochemical and Ethnobotanical Databases List of Chemicals for Dyspepsia/Indigestion
    Dr. Duke's Phytochemical and Ethnobotanical Databases List of Chemicals for Dyspepsia/Indigestion Chemical Activity Count (+)-ALLOMATRINE 1 (+)-ALPHA-VINIFERIN 1 (+)-BORNYL-ISOVALERATE 1 (+)-CATECHIN 3 (+)-EUDESMA-4(14),7(11)-DIENE-3-ONE 1 (+)-GALLOCATECHIN 2 (+)-HERNANDEZINE 1 (+)-ISOCORYDINE 1 (+)-PSEUDOEPHEDRINE 1 (+)-SYRINGARESINOL 1 (+)-SYRINGARESINOL-DI-O-BETA-D-GLUCOSIDE 1 (-)-16,17-DIHYDROXY-16BETA-KAURAN-19-OIC 1 (-)-ALPHA-BISABOLOL 5 (-)-ANABASINE 1 (-)-APOGLAZIOVINE 1 (-)-ARGEMONINE 1 (-)-BETONICINE 1 (-)-BISPARTHENOLIDINE 1 (-)-BORNYL-CAFFEATE 2 (-)-BORNYL-FERULATE 2 (-)-BORNYL-P-COUMARATE 2 (-)-DICENTRINE 2 (-)-EPICATECHIN 2 (-)-EPICATECHIN-3-O-GALLATE 1 (-)-EPIGALLOCATECHIN 1 (-)-EPIGALLOCATECHIN-3-O-GALLATE 1 (-)-EPIGALLOCATECHIN-GALLATE 2 Chemical Activity Count (-)-HYDROXYJASMONIC-ACID 1 (1'S)-1'-ACETOXYCHAVICOL-ACETATE 3 (2R)-(12Z,15Z)-2-HYDROXY-4-OXOHENEICOSA-12,15-DIEN-1-YL-ACETATE 1 (7R,10R)-CAROTA-1,4-DIENALDEHYDE 1 (E)-4-(3',4'-DIMETHOXYPHENYL)-BUT-3-EN-OL 1 1'-ACETOXY-EUGENOL-ACETATE 1 1'-ACETOXYCHAVICOL-ACETATE 1 1,2,11,13,2,3'-HEXAHYDROVERNODALIN 1 1,2,6-TRI-O-GALLOYL-BETA-D-GLUCOSE 1 1,7-BIS(3,4-DIHYDROXYPHENYL)HEPTA-4E,6E-DIEN-3-ONE 1 1,7-BIS-(4-HYDROXYPHENYL)-1,4,6-HEPTATRIEN-3-ONE 1 1,8-CINEOLE 7 1-METHYL-2-[(Z)-7-TRIDECENYL]-4-(1H)-QUINOLONE 1 1-METHYL-2-[(Z)-8-TRIDECENYL]-4-(1H)-QUINOLONE 1 1-O-(2,3,4-TRIHYDROXY-3-METHYL)-BUTYL-6-O-FERULOYL-BETA-D-GLUCOPYRANOSIDE 1 10-ACETOXY-8-HYDROXY-9-ISOBUTYLOXY-6-METHOXYTHYMOL 1 10-DEHYDROGINGERDIONE 1 10-GINGERDIONE 1 11(S),13-DIHYDRO-8-DEOXYLACTUCIN 1 11(S),13-DIHYDROLACTUCIN
    [Show full text]
  • Pelargonium and Acute Bronchitis in Children
    HerbalGram 95 • August-October 2012 English Translation of 17th Century Herbal Classic • DMAA Update • 100+ Year-Old TCM Company Curcumin and Rheumatoid Arthritis • Cannabidiol in Medicinal Cannabis • The University Medicinal Plant Garden The Journal of the American Botanical Council Number 95 | August - October 2012 100+ Year-Old TCM Company Company TCM • Year-Old and Curcumin 100+ Rheumatoid Arthritis • DMAA Update • of 17 Translation English Pelargonium and Acute th Century Herbal Classic Bronchitis in Children US/CAN $6.95 www.herbalgram.org www.herbalgram.org Herb Profile Cinnamon Cinnamomum verum Family: Lauraceae INTRODUCTION defines commercial grades of 3 types of cassia bark, Chinese Cinnamomum verum is a small-to-moderate, bushy, evergreen type cassia (C. aromaticum), Indonesian type cassia (C. burma- nii), and Vietnamese type cassia (C. loureirii), with a separate tree that grows to about 52 feet (16 m) in height with smooth, 6 pinkish bark.1-3 Fresh leaf growth, called a flush, begins in the ISO standard for cinnamon bark (C. verum). The American monsoon season (June through September) and varies from green Spice Trade Association allows both cassia and cinnamon bark 2 to be labeled and sold as cinnamon for seasoning and spice to deep purple. The fragrant flowers are small, pale yellowish- 7 M I S S I O N D R I V E N : green, and are attractive to insects, particularly bees. Cinnamo- purposes in food products. However, if cinnamon is used as mum verum is native to Sri Lanka and southern India, from sea a dietary supplement ingredient, US Food and Drug Adminis- level to 2,953 feet (900 m) and is cultivated in Sri Lanka, the tration (FDA) labeling regulations require use of the common coastal regions of India (in the Western Ghats and adjoining name consistent with the name standardized in the American Herbal Products Association’s Herbs of Commerce, 2nd ed., which hills), parts of Africa (Madagascar and the Seychelles), Indone- 8 sia (Java), South America (Brazil), and the West Indies.1,3 This does differentiate between cassia and cinnamon.
    [Show full text]